Phase 4 Haemophilia Trial, Recruiting NCT06864975 Sponsor: Runhui WU Condition: Haemophilia
Back to Haemophilia

Phase 4 Haemophilia Trial, Recruiting

NCT06864975
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have a severe form of hemophilia A, meaning your Factor VIII activity level is less than 2%
  • Your blood has developed inhibitors (antibodies) against Factor VIII treatment
  • You have not had an allergic reaction to Factor VIII concentrate products in the past

Who may not be able to join:

  • You have another condition that affects how your blood clots (besides hemophilia A)
  • You have a disorder affecting your blood or blood cells
  • You have an autoimmune disease (a condition where your immune system attacks your own body)
  • You have or have had cancer or another malignant disease

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: +86 010-59616623

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Runhui WU
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
1 March 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Success

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov